Abstract:Background: Naphthalimides have been receiving continuous attention for their outstanding performance in treating cancer. However, as a class of cytotoxic anti-tumor agents, their toxic side effects greatly limit their clinical application. Therefore, developing naphthalimide reagents with good selectivity for tumor cells is of great importance. Objective and Methods: A class of TEMPO-modified naphthalimide derivatives substituted with oxygen at the 6-position were designed, synthesized, and evaluated for the anti-tumor activity in vitro against three cancer cell lines (A549, MCF-7, and HeLa) as well as one normal human liver cell line (QSG-7701) by MTT assay. HRMS (or MS) and EPR spectra were used to identify the structures of target compounds. The UV–vis titration absorption spectra were performed to study the interaction between compounds and DNA. Results: The target compounds NT3, NT9, NT10, NT11, and NT12 exhibited moderate inhibition to all the three tested tumor cell lines, while NT1, NT2, and NT4 showed selectivity against A549, All the target compounds did not show measurable activities in QSG-7701, which imply the target compounds are likely to overcome the nonspecific toxicity against normal cells. UV-vis spectra showed this class of compounds could effectively intercalate into DNA and selectively bind to G-C base pairs. Conclusion: A novel class of TEMPO-modified naphthalimide derivatives substituted with oxygen at 6- position and the preliminary discussion on their SARs provide promising opportunities to guide further research on naphthalimide derivatives as anti-tumor agents.

Novel Melphalan and Chlorambucil Derivatives of 2,2,6,6-Tetramethyl-1-piperidinyloxy Radicals: Synthesis, Characterization, and Biological Evaluation <i>in Vitro</i>

ChemInform Abstract: Novel Melphalan and Chlorambucil Derivatives of 2,2,6,6‐tetramethyl‐1‐piperidinyloxy Radicals: Synthesis, Characterization, and Biological Evaluation in Vitro.

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Cytotoxicity of a Newly Synthesized Nitroxide Derivative of 4-Ferrocenecarboxyl-2,2,6,6-tetramethylpiperidine-1-oxyl in High Metastatic Lung Tumor Cells.

Synthesis of a Series of Novel Dihydroartemisinin Derivatives Containing a Substituted Chalcone with Greater Cytotoxic Effects in Leukemia Cells.

Design, Synthesis, and Biological Evaluation of a Class of TEMPOmodified Naphthalimide Derivatives with Good Selectivity for Tumor Cells

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.

Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Synthesis and Antileukemia Activity Evaluation of Benzophenanthridine Alkaloid Derivatives

Design, synthesis and in vitro evaluation of tylophorine derivatives as possible anti-tumor agents.

Benzylpiperazinyl derivatives of alepterolic acid: Synthesis and cytotoxic evaluation

Novel benzo chromene derivatives: design, synthesis, molecular docking, cell cycle arrest, and apoptosis induction in human acute myeloid leukemia HL-60 cells

Synthesis and Primary Anti-tumor Activities of 3-Fluoro-or 3-Amino-6-substituted-5,6-dihydropyrrolo [3,4-b] pyridin-7-ones

Synthesis And Evaluation Of Novel 2,4-Diaminopyrimidines Bearing A Sulfoxide Moiety As Anaplastic Lymphoma Kinase (Alk) Inhibition Agents

Synthesis And In Vitro Cytotoxic Evaluation Of Novel -(3,4,5-Trimethoxyphenyl)Pyridin-2()-One Derivatives

Synthesis and biological evaluation of novel N -(piperazin-1-yl)alkyl-1 H -dibenzo[ a , c ]carbazole derivatives of dehydroabietic acid as potential MEK inhibitors.

Modification of the Alkylating Agent Chlorambucil with Spiropiperazinium Salts

Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents.

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis and Anti-tumor Activity Evaluation of a Series of 2-or 4-Substituted Pyrido [3,2-D] Pyrimidines As Nonclassical Antifolates

Novel Melphalan and Chlorambucil Derivatives of 2,2,6,6-Tetramethyl-1-piperidinyloxy Radicals: Synthesis, Characterization, and Biological Evaluation &lt;i&gt;in Vitro&lt;/i&gt;